Erratum: Sex differences in biomarkers associated with insulin resistance in obese adolescents: Metabolomic profiling and principal components analysis (Journal of Clinical Endocrinology and Metabolism (2014) 99 (4730-4739) DOI: 10.1210/jc.2014-2080);Sex differences in biomarkers associated with insulin resistance in obese adolescents: Metabolomic profiling and principal components analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages 4730-4739

  Newbern, Dorothee ^a   Balikcioglu, Pinar Gumus ^a   Balikcioglu, Metin ^c   Bain, James ^b   Muehlbauer, Michael ^b   Stevens, Robert ^b   Ilkayeva, Olga ^b   Dolinsky, Diana ^a   Armstrong, Sarah ^a   Irizarry, Krystal ^a   Freemark, Michael ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAS INSTITUTE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ADIPONECTIN; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; HIGH DENSITY LIPOPROTEIN; LEPTIN; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CATABOLISM; CHILDHOOD OBESITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FEMALE; HOMEOSTASIS MODEL ASSESSMENT INDEX OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; PUBERTY; SEX DIFFERENCE; TRIGLYCERIDE TO HIGH DENSITY LIPOPROTEIN RATIO; ANTHROPOMETRY; BLOOD; CHILD; METABOLISM; METABOLOME; OBESITY; SEXUAL DEVELOPMENT;

ADIPONECTIN; ADOLESCENT; AMINO ACIDS, BRANCHED-CHAIN; ANTHROPOMETRY; BIOMARKERS; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPOPROTEINS, HDL; MALE; METABOLOME; OBESITY; PRINCIPAL COMPONENT ANALYSIS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 84916608287     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1354     Document Type: Erratum

References (40)

1. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138-1145.
2. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005;116:473-480.
3. Li C, Ford ES, Zhao G, Mokdad AH. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among US adolescents: NHANES 2005-2006. Diabetes Care. 2009;32:342-347.
4. Levy-Marchal C, Arslanian S, Cutfield W, et al. ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE; Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010;95:5189-5198.
5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
6. An J, Muoio DM, Shiota M, et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole animal insulin resistance. Nat Med. 2004;10:268-274.
7. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13:321-324.
8. Wu JY, Kao HJ, Li SC, et al. ENU mutagenesis identifies mice with mitochondrial branched chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest. 2004;113:434-440.
9. Chace DH, Hillman SL, Millington DS, Kahler SG, Roe CR, Naylor EW. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem. 1995;41:62-68.
10. Ferrara CT, Wang P, Neto EC, et al. Genetic network of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet. 2008;4(3):e1000034.
11. O'Rourke N, Hatcher L. A Step-by-Step Approach to Using SAS for Factor Analysis and Structural Equation Modeling. 2nd ed. Cary, NC: SAS Publishing; 2014:1-42.
12. Newgard CB, An J, Bain JR, et al. A branched-chain amino acidrelated metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311-326.
13. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes. 2009;58:2429-2443.
14. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448-453.
15. Batch BC, Shah SH, Newgard CB, et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism. 2013;62(7):961-969.
16. Shah SH, Bain JR, Muehlbauer MJ, et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet. 2010;3(2):207-214.
17. Bain JR. Targeted metabolomics finds its mark in diabetes research. Diabetes. 2013;62(2):349-351.
18. Mihalik SJ, Michaliszyn SF, de las Heras J, et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012;35(3):605-611.
19. Michaliszyn SF, Sjaarda LA, Mihalik SJ, et al. Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012;97(11):E2119-E2124.
20. McCormack SE, Shaham O, McCarthy MA, et al. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes. 2013;8:52-61.
21. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15-E26.
22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-1495.
23. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27(7):762-778.
24. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257(2):167-175.
25. Winer JC, Zern TL, Taksali SE, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415-4423.
26. Giannini C, Santoro N, Caprio S, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 2011;34(8):1869-1874.
27. Newgard CB. Interplay between lipids and branched chain amino acids in development of insulin resistance. Cell Metab. 2012;15:606-614.
28. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:193-205.
29. Koves TR, Li P, An J, et al. Peroxisomal proliferator-activated receptor-γ co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280:33588-33598.
30. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45-56.
31. Lowe WL Jr, Bain JR. "Prediction is very hard, especially about the future": new biomarkers for type 2 diabetes? Diabetes. 2013;62(5):1384-1385.
32. Ferrannini E, Natali A, Camastra S, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. 2013;62:1730-1737.
33. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA. 2000 7;97(23):12729-12734.
34. Bryzgalova G1, Gao H, Ahren B, et al. Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006;49(3):588-597.
35. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759-763.
36. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50(11):2444-2450.
37. Brufani C, Tozzi A, Fintini D, et al. Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol. 2009;160(5):769-775.
38. Huffman KM, Shah SH, Stevens RD, et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009;32(9):1678-1683.
39. Copeland KC, Zeitler P, Geffner M, et al. TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1):159-167.
40. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-2256.